- Home
- PII vs PCVX Comparison
PII vs PCVX Comparison
Compare PII & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PII
- PCVX
- Stock Information
- Founded
- PII 1954
- PCVX 2013
- Country
- PII United States
- PCVX United States
- Employees
- PII N/A
- PCVX N/A
- Industry
- PII Recreational Games/Products/Toys
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- PII Consumer Discretionary
- PCVX Health Care
- Exchange
- PII Nasdaq
- PCVX Nasdaq
- Market Cap
- PII 3.6B
- PCVX 4.0B
- IPO Year
- PII 1987
- PCVX 2020
- Fundamental
- Price
- PII $66.10
- PCVX $45.28
- Analyst Decision
- PII Hold
- PCVX Strong Buy
- Analyst Count
- PII 11
- PCVX 8
- Target Price
- PII $52.60
- PCVX $114.17
- AVG Volume (30 Days)
- PII 1.6M
- PCVX 1.6M
- Earning Date
- PII 10-28-2025
- PCVX 11-05-2025
- Dividend Yield
- PII 4.05%
- PCVX N/A
- EPS Growth
- PII N/A
- PCVX N/A
- EPS
- PII N/A
- PCVX N/A
- Revenue
- PII $7,076,200,000.00
- PCVX N/A
- Revenue This Year
- PII N/A
- PCVX N/A
- Revenue Next Year
- PII $3.49
- PCVX N/A
- P/E Ratio
- PII N/A
- PCVX N/A
- Revenue Growth
- PII N/A
- PCVX N/A
- 52 Week Low
- PII $30.92
- PCVX $27.66
- 52 Week High
- PII $75.25
- PCVX $116.00
- Technical
- Relative Strength Index (RSI)
- PII 53.15
- PCVX 66.85
- Support Level
- PII $65.44
- PCVX $43.12
- Resistance Level
- PII $68.99
- PCVX $45.69
- Average True Range (ATR)
- PII 3.35
- PCVX 1.67
- MACD
- PII -0.32
- PCVX -0.12
- Stochastic Oscillator
- PII 13.68
- PCVX 90.79
About PII Polaris Inc.
Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, including motorcycles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to another segment of the outdoor lifestyle market. Polaris products are retailed through more than 2,500 dealers in North America and 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.